Neoantigen trailblazers, from the likes of Vaccibody, Targovax, Vaimm, Vaxon Biotech and more are uniting in Amsterdam this April 2022, to supercharge the engineering of personalised neoantigen and shared antigen vaccines and cell-based immunotherapies through robust prediction, enhanced identification, and critical validation.

Download our full event guide to see all our new speakers, agenda topics and in-person networking opportunities planned for our 5th edition. We are committed so running a safe event see out full T&Cs and booking with confidence statement enclosed.